SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Diplomat Pharmacy, Inc. And Advises Investors With Losses To Contact The Firm

Goldberg Law PC announces that it is investigating Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) concerning possible violations of federal securities laws.

If you purchased or otherwise acquired Diplomat shares and would like more information regarding the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm's website at, or by email at

On November 2, 2016, Diplomat announced third quarter 2016 results that fell below investors' expectations. The Company also lowered full year 2016 guidance. When this news was announced, shares of Diplomat fell in value.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at, or email us at

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on
Copyright Business Wire 2010

If you liked this article you might like

5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More

5 Earnings Short-Squeeze Plays to Boost Your Returns

Bullish and Bearish Reversals for the Week

SBUX, AAPL, FB: Jim Cramer's Views